- Medicina i Cirurgia
Departament
![Foto de Jaime](/img/nophoto.png)
Jaime
Feliu Batlle
Publicacions en què col·labora amb Jaime Feliu Batlle (15)
2023
-
Prognostic evaluation in patients with advanced cancer in the last months of life: ESMO Clinical Practice Guideline ☆
ESMO Open, Vol. 8, Núm. 2
-
Total neoadjuvant therapy with or without aflibercept in rectal cancer: 3-year results of GEMCAD-1402
Journal of the National Cancer Institute, Vol. 115, Núm. 12, pp. 1497-1505
2019
2018
-
Coexpression of p-IGF-1R and MMP-7 Modulates Panitumumab and Cetuximab Efficacy in RAS Wild-Type Metastatic Colorectal Cancer Patients
Neoplasia (United States), Vol. 20, Núm. 7, pp. 678-686
2017
-
Dynamic soluble changes in sVEGFR1, HGF, and VEGF promote chemotherapy and bevacizumab resistance: A prospective translational study in the BECOX (GEMCAD 09-01) trial
Tumor Biology, Vol. 39, Núm. 6
-
Nuclear IGF-1R predicts chemotherapy and targeted therapy resistance in metastatic colorectal cancer
British Journal of Cancer, Vol. 117, Núm. 12, pp. 1777-1786
2015
-
Clinical guideline SEOM: hepatocellular carcinoma
Clinical and Translational Oncology, Vol. 17, Núm. 12, pp. 988-995
-
Correlation of hypertension and proteinuria with outcome in elderly bevacizumab-treated patients with metastatic colorectal cancer
PLoS ONE, Vol. 10, Núm. 1
2014
-
First-line bevacizumab and capecitabine-oxaliplatin in elderly patients with mCRC: GEMCAD phase II BECOX study
British Journal of Cancer, Vol. 111, Núm. 2, pp. 241-248
-
Preoperative chemotherapy in patients with intermediate-risk rectal adenocarcinoma selected by high-resolution magnetic resonance imaging: The GEMCAD 0801 phase II multicenter trial
Oncologist, Vol. 19, Núm. 10, pp. 1042-1043
2011
-
Recommendations and expert opinion on the adjuvant treatment of colon cancer in Spain
Clinical and Translational Oncology, Vol. 13, Núm. 11, pp. 798-804
2010
-
Capecitabine and bevacizumab as first-line treatment in elderly patients with metastatic colorectal cancer
British Journal of Cancer, Vol. 102, Núm. 10, pp. 1468-1473
2006
-
XELOX (capecitabine plus oxaliplatin) as first-line treatment for elderly patients over 70 years of age with advanced colorectal cancer
British Journal of Cancer, Vol. 94, Núm. 7, pp. 969-975
2005
-
Phase II randomised trial of raltitrexed-oxaliplatin vs raltitrexed-irinotecan as first-line treatment in advanced colorectal cancer
British Journal of Cancer, Vol. 93, Núm. 11, pp. 1230-1235
2004
-
Irinotecan plus raltitrexed as first-line treatment in advanced colorectal cancer: A phase II study
British Journal of Cancer, Vol. 90, Núm. 8, pp. 1502-1507